PIAZZA ROCCO GIOVANNI

Ducci, G., Ciufolini, G., Campioni, G., Pasquale, V., Gigliotti, G., Ponzetto, S., et al. (2026). FGFR3 oncogenic activation drives oxidative metabolic reprogramming in bladder cancer: a systems metabolomics approach. COMMUNICATIONS BIOLOGY [10.1038/s42003-026-10356-z]. Dettaglio

Civettini, I., Malighetti, F., Villa, M., Crippa, V., Aroldi, A., Cavalca, F., et al. (2026). Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution. NEJM EVIDENCE, 5(6), 1-13 [10.1056/evidoa2500124]. Dettaglio

Barone, C., Quattrini, G., Muratore, A., Anselmi, G., Park, Y., Mehmood, N., et al. (2026). Fetal-restricted hematopoietic progenitors arise from hemogenic endothelium in vitelline and umbilical arteries. NATURE CARDIOVASCULAR RESEARCH [10.1038/s44161-026-00793-8]. Dettaglio

Crippa, V., Cordani, N., Villa, A., Malighetti, F., Villa, M., Sala, L., et al. (2025). Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) [Altro] [10.1038/s41698-025-01114-1]. Dettaglio

Villa, M., Malighetti, F., De, S., Villa, A., Cordani, N., Aroldi, A., et al. (2025). Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors. NUCLEIC ACIDS RESEARCH, 53(13 (22 July 2025)) [10.1093/nar/gkaf648]. Dettaglio